Mousnier, Aurélie http://orcid.org/0000-0002-7317-1009
Bell, Andrew S. http://orcid.org/0000-0002-0581-9387
Swieboda, Dawid P.
Morales-Sanfrutos, Julia
Pérez-Dorado, Inmaculada
Brannigan, James A. http://orcid.org/0000-0001-6597-8972
Newman, Joseph
Ritzefeld, Markus
Hutton, Jennie A.
Guedán, Anabel
Asfor, Amin S.
Robinson, Sean W.
Hopkins-Navratilova, Iva
Wilkinson, Anthony J. http://orcid.org/0000-0003-4577-9479
Johnston, Sebastian L.
Leatherbarrow, Robin J.
Tuthill, Tobias J. http://orcid.org/0000-0002-6582-388X
Solari, Roberto http://orcid.org/0000-0002-7660-3460
Tate, Edward W. http://orcid.org/0000-0003-2213-5814
Article History
Received: 14 August 2017
Accepted: 1 March 2018
First Online: 14 May 2018
Competing interests
: A.B., E.W.T., R.J.L., J.A.H. and J.A.B. are inventors on a patent application that describes NMT inhibitors that includeInternalRef removedandInternalRef removed(Bell, A.S.; Tate, E.W.; Leatherbarrow, R.J.; Hutton, J.A.; Brannigan, J.A., Compounds and their use as inhibitors of N-myristoyl transferase, Patent Cooperation Treaty International Application (2017) WO 2017001812).